Avalanche Biotechnologies(AAVL)

Bluebird - Best of Breed in Gene Therapy

name9982015-06-13 22:06

$BLUEBIRD BIO INC(BLUE)$ updated their data in Severe SCD program and Beta-Thalassemia earlier this morning (June-13, 2015) at the 20th Congress of the European Hematology Association (EHA) in Vienna.
Data looks awesome . Looks like they did cured the SC...查看全文

淡投2015-06-11 00:16

$Avalanche Biotechnologies(AAVL)$
Avalanche Bio Gene Therapy Preview: What to Expect From Eye Study网页链接查看全文

好祖2015-06-07 15:11

$Avalanche Biotechnologies(AAVL)$ 四周前收出了一个morning star，现在再次打回前期颈线位。这只股票个人一直在关注，周五收出一根突破性中阳，短期上冲动力比较大查看全文

郑坚强2015-05-22 23:11

$Avalanche Biotechnologies(AAVL)$ 马上要公布phase2数据了，如果数据好直接翻倍，附上phase1数据和市场空间，目前市值9.7亿。赌徒们谨慎下注@每日一拜FDA查看全文

Concentrate on core competencies

name9982015-05-20 11:45

$BLUEBIRD BIO INC(BLUE)$ this company is the leading horseman in GENE THERAPY area. They have three MAIN value drivers: Beta-Thalassemia, Sickle Cell Disease (SCD) and CCALD. Of course, they also work with $新基(CELG)$ in the EXTREMELY HOT (stretched valuation) CAR-T area. H...查看全文

割资本主义羊毛2015-05-05 00:14

Three persons treated w gene therapy for LCA showed visual acuity improved, then declined.
网页链接
$uniQure(QURE)$ $Celladon Corporation(CLDN)$ $Avalanche Biotechnologies(AAVL)$ $BLUEBIRD BIO INC(BLUE)$ $Applied Gen...查看全文

疑夕2015-05-04 23:34

$Celladon Corporation(CLDN)$ 失败后，整个基因疗法二级市场形成恐慌，$uniQure(QURE)$ $Avalanche Biotechnologies(AAVL)$ $BLUEBIRD BIO INC(BLUE)$ $Applied Genetic Technologies(AGTC)$ $SPARK THERAPEUTICS INC(ONCE)$ 全线坍塌，个人仍然看好这项技术，大部分遗传病的希望都在这。查看全文

重剑无锋20242015-03-18 21:23

$Avalanche Biotechnologies(AAVL)$ 昨晚难道是入场的良机？已买入，看多！[看多]查看全文

郑坚强2015-03-14 18:21

$Avalanche Biotechnologies(AAVL)$ 买入的好时机，技术上已经突破，如果年中2期数据没问题直接翻倍查看全文

摩揭提2015-02-27 12:28

$Avalanche Biotechnologies(AAVL)$ 它的发行价是多少啊查看全文

$Avalanche Biotechnologies(AAVL)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-11-16 AccNo: 0001493152-18-016327 Size: 169 KB 网页链接

$Avalanche Biotechnologies(AAVL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-08 AccNo: 0001564590-18-028654 Size: 4 MB 网页链接

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2018-10-24 AccNo: 0001193125-18-306392 Size: 16 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2018-10-17 AccNo: 0001193125-18-301082 Size: 13 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$Avalanche Biotechnologies(AAVL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-08 AccNo: 0001564590-18-020510 Size: 5 MB 网页链接

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2018-07-02 AccNo: 0001193125-18-211393 Size: 16 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of...

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2018-06-15 AccNo: 0001193125-18-194580 Size: 16 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2018-06-01 AccNo: 0001193125-18-181838 Size: 19 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接

$Avalanche Biotechnologies(AAVL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-09 AccNo: 0001564590-18-012437 Size: 4 MB 网页链接

$Avalanche Biotechnologies(AAVL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-09 AccNo: 0001564590-18-012437 Size: 4 MB 网页链接